Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)

NCT02942199 is registered in ClinicalTrials.gov with Cambridge Health Alliance as lead sponsor.

NCT NCT02942199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02942199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)
Lead sponsor
Cambridge Health Alliance
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2016
Completion date
August 31, 2018
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder